Sun Pharma recalls 10 eye-drop brands over contamination concerns
Sun Pharma has asked distributors to stop billing, report inventory and return stocks of 10 ophthalmic brands in India, amid heightened scrutiny of sterile eye-drop quality.
Sun Pharma has recalled 10 ophthalmic brands in India over contamination concerns, directing distributors to stop billing, report inventory and return stocks. The precautionary move highlights heightened quality scrutiny for sterile eye-drop products.
Why this matters
The action follows recent signals that Sun Pharma recalled select eye drops in India and halted distribution of multiple ophthalmic products as a precaution, indicating continued quality-control pressure in its eye-care portfolio.
Retail-company signals are accelerating, up 222450% QoQ.